Originally published by our sister publication Infectious Disease Special Edition
The FDA approved the first nasal spray influenza vaccine that can be administered by the patient or caregiver at home. Influenza Vaccine Live, Intranasal (FluMist, MedImmune) is approved for the prevention of influenza caused by influenza virus subtypes A and B in people 24 months through 49 years of age.
FluMist is a live-attenuated influenza vaccine that is sprayed into the nose and has been used safely and